Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 315-319

  Pamplona, Reinald ^a   Ilieva, Ekaterina ^a   Ayala, Victoria ^a   Bellmunt, Maria Josep ^a   Cacabelos, Daniel ^a   Dalfo, Esther ^a   Ferrer, Isidre ^a   Portero Otin, Manuel ^a  

^a Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

Author keywords

Advanced glycation end products; Advanced lipoxidation end products; Alzheimer's disease; Amyotrophic lateral sclerosis; Creutzfeldt Jakob disease; Energy metabolism; Free radicals; Mitochondria; Oxidative stress; Parkinson's disease; Pick's disease

Indexed keywords

ENZYME;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DIFFUSE LEWY BODY DISEASE; ENERGY METABOLISM; ENZYME MODIFICATION; GENETIC ASSOCIATION; GLYCATION; HOMEOSTASIS; HUMAN; MITOCHONDRION; NERVE DEGENERATION; OXIDATIVE STRESS; PARKINSON DISEASE; PICK PRESENILE DEMENTIA; PROTEIN AGGREGATION; PROTEIN FOLDING;

EID: 42549135905     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.014     Document Type: Conference Paper

References (12)

1. 1 Sanz, A., R. Pamplona & G. Barja. 2006. Is the mitochondrial free radical theory of aging intact? Antioxid. Redox Signal. 8: 582–599.
2. 2 Thorpe, S.R. & J.W. Baynes. 2003. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 25: 275–281.
3. 3 Portero‐Otin, M. & R. Pamplona. 2006. Is endogenous oxidative protein damage envolved in the aging process?. In Recent Research Developments in Pathological Biochemistry. Vol. 1 Protein Oxidation and Disease. J. Pietzsch, Ed.: 91–142. Research Signpost. Kerala, India.
4. 4 Hulbert, A.J., R. Pamplona, R. Buffenstein & W.A. Buttemer. 2007. Life and death: metabolic rate, membrane composition and life span of animals. Physiol. Rev. doi: DOI: 10.1152/physrev.00047.2006.
5. 5 Mattson, M.P. & T. Magnus. 2006. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7: 278–294.
6. 6 Barja, G. 2004. Free radicals and aging. Trends Neurosci. 27: 595–600.
7. 7 Pamplona, R., E. Dalfo, V. Ayala, et al. 2005. Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation: Effects of Alzheimer's disease and identification of lipoxidation targets. J. Biol. Chem. 280: 21522–21530.
8. 8 Muntane, G., E. Dalfo, A. Martinez, et al. 2006. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease. J. Neurochem. 99: 177–185.
9. 9 Castellani, R., M.A. Smith, P.L. Richey, et al. 1996. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737: 195–200.
10. 10 Dalfo, E., M. Portero‐Otin, V. Ayala, et al. 2005. Evidence of oxidative stress in the neocortex in incidental Lewy body disease. J. Neuropathol. Exp. Neurol. 64: 816–830.
11. 11 Hu, M.T., S.D. Tayor‐Robinson, K.R. Chaudhuri, et al. 2000. Cortical dys function in non‐demented Parkinson's disease patients: a combined (31) P‐MRS and (18) FDG‐PET study. Brain 123: 340–352.
12. 12 Ilieva, E., V. Ayala, M. Jove, et al. 2007. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain, doi: DOI: 10.1093/brain/awm190.